These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30370853)

  • 1. 3D-QSAR and Molecular Docking Studies on Design Anti-Prostate Cancer Curcumin Analogues.
    Meng X; Cui L; Song F; Luan M; Ji J; Si H; Duan Y; Zhai H
    Curr Comput Aided Drug Des; 2020; 16(3):245-256. PubMed ID: 30370853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The three dimensional Quantitative Structure Activity Relationships (3D-QSAR) and docking studies of curcumin derivatives as androgen receptor antagonists.
    Xu G; Chu Y; Jiang N; Yang J; Li F
    Int J Mol Sci; 2012; 13(5):6138-6155. PubMed ID: 22754355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of Novel Chemotherapeutic Agents Targeting Checkpoint Kinase 1 Using 3D-QSAR Modeling and Molecular Docking Methods.
    Balupuri A; Balasubramanian PK; Cho SJ
    Curr Comput Aided Drug Des; 2016; 12(4):302-313. PubMed ID: 27585602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and evaluation of novel heteroaromatic analogs of curcumin as anti-cancer agents.
    Samaan N; Zhong Q; Fernandez J; Chen G; Hussain AM; Zheng S; Wang G; Chen QH
    Eur J Med Chem; 2014 Mar; 75():123-31. PubMed ID: 24531225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin-Synthetic Analogs Library Screening by Docking and Quantitative Structure-Activity Relationship Studies for AXL Tyrosine Kinase Inhibition in Cancers.
    Ghrifi F; Allam L; Wiame L; Ibrahimi A
    J Comput Biol; 2019 Oct; 26(10):1156-1167. PubMed ID: 31009237
    [No Abstract]   [Full Text] [Related]  

  • 6. 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors.
    Chaube U; Bhatt H
    Mol Divers; 2017 Aug; 21(3):741-759. PubMed ID: 28577112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of 1,9-diheteroarylnona-1,3,6,8-tetraen-5-ones as a new class of anti-prostate cancer agents.
    Zhang X; Wang R; Perez GR; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
    Bioorg Med Chem; 2016 Oct; 24(19):4692-4700. PubMed ID: 27543391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of curcumin derivatives as human glyoxalase I inhibitors: A combination of biological evaluation, molecular docking, 3D-QSAR and molecular dynamics simulation studies.
    Yuan M; Luo M; Song Y; Xu Q; Wang X; Cao Y; Bu X; Ren Y; Hu X
    Bioorg Med Chem; 2011 Feb; 19(3):1189-96. PubMed ID: 21237663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational analyses of curcuminoid analogs against kinase domain of HER2.
    Yim-im W; Sawatdichaikul O; Semsri S; Horata N; Mokmak W; Tongsima S; Suksamrarn A; Choowongkomon K
    BMC Bioinformatics; 2014 Aug; 15(1):261. PubMed ID: 25089037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor agents. 250. Design and synthesis of new curcumin analogues as potential anti-prostate cancer agents.
    Lin L; Shi Q; Nyarko AK; Bastow KF; Wu CC; Su CY; Shih CC; Lee KH
    J Med Chem; 2006 Jun; 49(13):3963-72. PubMed ID: 16789753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of 1,7-diheteroarylhepta-1,4,6-trien-3-ones as curcumin-based anticancer agents.
    Wang R; Zhang X; Chen C; Chen G; Zhong Q; Zhang Q; Zheng S; Wang G; Chen QH
    Eur J Med Chem; 2016 Mar; 110():164-80. PubMed ID: 26827161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Modeling Study for the Design of Novel Peroxisome Proliferator-Activated Receptor Gamma Agonists using 3D-QSAR and Molecular Docking.
    Jian Y; He Y; Yang J; Han W; Zhai X; Zhao Y; Li Y
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29473866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and Synthesis of Curcumin-Like Diarylpentanoid Analogues as Potential Anticancer Agents.
    Qudjani E; Iman M; Davood A; Ramandi MF; Shafiee A
    Recent Pat Anticancer Drug Discov; 2016; 11(3):342-51. PubMed ID: 27094172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docking-based 3D-QSAR study of pyridyl aminothiazole derivatives as checkpoint kinase 1 inhibitors.
    Balupuri A; Balasubramanian PK; Gadhe CG; Cho SJ
    SAR QSAR Environ Res; 2014; 25(8):651-71. PubMed ID: 24911214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents.
    Ohtsu H; Xiao Z; Ishida J; Nagai M; Wang HK; Itokawa H; Su CY; Shih C; Chiang T; Chang E; Lee Y; Tsai MY; Chang C; Lee KH
    J Med Chem; 2002 Nov; 45(23):5037-42. PubMed ID: 12408714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel anti-prostate cancer curcumin analogues that enhance androgen receptor degradation activity.
    Shi Q; Shih CC; Lee KH
    Anticancer Agents Med Chem; 2009 Oct; 9(8):904-12. PubMed ID: 19663790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor agents 247. New 4-ethoxycarbonylethyl curcumin analogs as potential antiandrogenic agents.
    Lin L; Shi Q; Su CY; Shih CC; Lee KH
    Bioorg Med Chem; 2006 Apr; 14(8):2527-34. PubMed ID: 16427289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D-QSAR (CoMFA, CoMSIA) and Molecular Docking Studies on Histone Deacetylase 1 Selective Inhibitors.
    Abdizadeh T; Ghodsi R; Hadizadeh F
    Recent Pat Anticancer Drug Discov; 2017 Nov; 12(4):365-383. PubMed ID: 28482791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chloro and bromo-pyrazole curcumin Knoevenagel condensates augmented anticancer activity against human cervical cancer cells: design, synthesis,
    Chaudhary M; Kumar N; Baldi A; Chandra R; Arockia Babu M; Madan J
    J Biomol Struct Dyn; 2020 Jan; 38(1):200-218. PubMed ID: 30784365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, biological evaluation and molecular docking of 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs containing the piperazine moiety.
    Chen H; Zhang J; Hu P; Qian Y; Li J; Shen J
    Bioorg Med Chem; 2019 Oct; 27(20):115081. PubMed ID: 31493989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.